Form 4 for BMRN BIOMARIN PHARMACEUTICAL INC
Accepted 2025-03-20 00:00:00 ET · period of report 2025-03-19 · accession 0001048477-25-000041 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-20 | 2025-03-19 | BMRN | Burkhart Erin | CAO, GVP | S - Sale | $71.52 | -1,295 | 17.0K | -7% | -$92.6K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-03-19 | S | D | 1,295 | $71.52 | 16,955 | D | — | — | (F1) Trade made pursuant to a 10b5-1 plan executed on November 26, 2024. (F2) The Reporting Person's direct holdings have been adjusted by two shares to correct a previous clerical error. |